RxDoctor Payments Data

Jessica Valdez

Pediatric Hematology-Oncology · Albuquerque, NMNPI 1750673661

Payments from drug & device makers

$347,325in general payments, 2019–2025

Across 34 payments — averaging $10,215 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$342K
  • E.r. Squibb & Sons, L.L.C.$3K
  • Day One Biopharmaceuticals$2K
  • Jazz Pharmaceuticals Inc.$345
  • Adaptive Biotechnologies Corporation$190
  • Genentech USA, Inc.$124
  • plus $287 from 4 others

What the payments were for

  • Consulting fees$1,59058%
  • Food & beverage$1,17442%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric hematology-oncology providers in New Mexicoto place this figure against a meaningful peer group, so we don't.

Other pediatric hematology-oncology in Albuquerque

Where these figures come from

Is this you, or does something look wrong? →